Co-founded in 2009 by Pierre Jérôme and Stéphane Bette, former executives at Medtronic Sofamor-Danek and SpineVision, SpineGuard®’s primary objective is to establish its FDA-cleared and CE Marked PediGuard® device as the global standard of care for spinal screw placement.
Co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer, PediGuard is the world’s first and only handheld device capable of alerting surgeons to potential pedicular or vertebral breaches. Real-time feedback is provided via audio and visual signals. Nearly 17,000 procedures have been performed with PediGuard on all continents. Clinical studies of PediGuard have been published demonstrating that PediGuard doubles the pedicle breach detection rate, limits radiation exposure by 30 percent, decreases by up to 10 percent the average time for pedicle screw placement and provides a 3 fold reduction in neuro-monitoring events.
To further demonstrate the superior clinical effectiveness and economic relevance of PediGuard, SpineGuard is focused on 3 key operational objectives: increase market adoption, conduct new clinical studies and drive innovation. The company just launched PediGuard Curv and is preparing for the limited release of its highly anticipated Cannulated PediGuard, a “smart Jamshidi needle” to address minimally invasive spine surgery.
SpineGuard’s mission is to make spine surgery safer. The company has offices in San Francisco and Paris.